(Q43257954)

17 November 2017

title

Metabolic responses to long-term pharmacological inhibition of CB1-receptor activity in mice in relation to dietary fat composition (English)

1 reference

17 November 2017

2

1 reference

17 November 2017

A H Koolman

1

1 reference

17 November 2017

M H Oosterveer

3

1 reference

17 November 2017

I Jonas

4

1 reference

17 November 2017

F Kuipers

5

1 reference

17 November 2017

P J J Sauer

6

1 reference

17 November 2017

G van Dijk

7

1 reference

17 November 2017

language of work or name

English

0 references

publication date

20 October 2009

1 reference

International Journal of Obesity

17 November 2017

published in

1 reference

17 November 2017

volume

34

1 reference

17 November 2017

issue

2

1 reference

17 November 2017

page(s)

374-384

1 reference

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

Assessment of energy expenditure and fuel utilization in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

The endocannabinoid system and energy metabolism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Endocannabinoids and the control of energy balance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Effects of dietary fatty acids and exercise on body-weight regulation and metabolism in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

A rapid and sensitive sub-micro phosphorus determination

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Obesity-associated improvements in metabolic profile through expansion of adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.219

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.219

1 reference

Dimensions Publication ID

17 November 2017

1034964014

0 references

1 reference